Cargando…
COVID-19 in Pediatric Patients: A Focus on CHD Patients
Coronavirus disease 2019 (COVID-19) is a global pandemic caused by SARS-CoV-2 virus. As of the 30th of September 2020, around 34,000,000 cases have been reported globally. Pediatrics with underlying congenital heart disease represent a small yet a critical proportion of these patients. In general, t...
Autores principales: | Zareef, Rana O., Younis, Nour K., Bitar, Fadi, Eid, Ali H., Arabi, Mariam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728667/ https://www.ncbi.nlm.nih.gov/pubmed/33330675 http://dx.doi.org/10.3389/fcvm.2020.612460 |
Ejemplares similares
-
COVID-19: potential therapeutics for pediatric patients
por: Younis, Nour K., et al.
Publicado: (2021) -
COVID-19 in congenital heart disease patients: what did we learn?!
por: Zareef, Rana, et al.
Publicado: (2023) -
Cardiac Manifestations in COVID-19 Patients: A Focus on the Pediatric Population
por: Abi Nassif, Tania, et al.
Publicado: (2021) -
Pulmonary artery debanding in the cath lab: Lessons learned!
por: Zareef, Rana, et al.
Publicado: (2022) -
Hydroxychloroquine in COVID-19 Patients: Pros and Cons
por: Younis, Nour K., et al.
Publicado: (2020)